ERP timeline
Every ERP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| ERP-2605-M7608 | Selank | 25 May 2026 | 2026-Q2 | 1 | 99.75 | n<2 | 99.90 | +0.15 | |
| ERP-2605-E7682 | Survodutide | 11 May 2026 | 2026-Q3 | 4 | 98.13 | 0.81 | 98.76 | +0.63 | |
| ERP-2605-S8022 | TB-500 | 08 May 2026 | 2026-Q3 | 4 | 99.55 | 0.42 | 99.90 | +0.35 | |
| ERP-2604-W7280 | Tesamorelin | 17 Apr 2026 | 2026-Q3 | 12 | 98.80 | 1.46 | 98.79 | -0.01 | |
| ERP-2604-K8139 | GHK-Cu | 14 Apr 2026 | 2026-Q2 | 3 | 98.34 | 1.23 | 99.18 | +0.84 | |
| ERP-2603-D7882 | Mazdutide | 03 Mar 2026 | 2026-Q2 | 6 | 97.54 | 0.93 | 97.97 | +0.43 | |
| ERP-2601-X6637 | Glucagon | 24 Jan 2026 | 2026-Q1 | 2 | 98.03 | 0.25 | 98.81 | +0.78 | |
| ERP-2601-F7633 | GHK-Cu | 16 Jan 2026 | 2026-Q2 | 9 | 98.53 | 0.64 | 99.12 | +0.59 | |
| ERP-2601-P6802 | Liraglutide | 15 Jan 2026 | 2026-Q2 | 8 | 98.48 | 0.77 | 98.95 | +0.47 | |
| ERP-2601-P6603 | Humanin (HNG) | 03 Jan 2026 | 2026-Q1 | 6 | 98.88 | 1.08 | 99.37 | +0.49 | |
| ERP-2512-T7433 | Tirzepatide | 12 Dec 2025 | 2026-Q2 | 3 | 99.11 | 0.49 | 98.98 | -0.13 | |
| ERP-2512-G6974 | Semax | 10 Dec 2025 | 2026-Q1 | 9 | 99.81 | 0.88 | 99.68 | -0.13 | |
| ERP-2511-L7123 | TB-500 | 10 Nov 2025 | 2025-Q4 | 8 | 98.88 | 1.08 | 99.35 | +0.47 | |
| ERP-2509-A8587 | Semaglutide | 28 Sep 2025 | 2025-Q4 | 9 | 97.88 | 1.30 | 97.74 | -0.14 | |
| ERP-2509-G8440 | BPC-157 | 23 Sep 2025 | 2026-Q1 | 2 | 98.93 | 0.33 | 99.04 | +0.11 | |
| ERP-2509-K6500 | PEG-MGF | 22 Sep 2025 | 2026-Q1 | 3 | 98.08 | 0.44 | 98.50 | +0.42 | |
| ERP-2509-K7157 | TB-500 | 10 Sep 2025 | 2025-Q4 | 4 | 98.99 | 0.65 | 99.72 | +0.73 | |
| ERP-2508-R7431 | Kisspeptin-10 | 18 Aug 2025 | 2025-Q4 | 1 | 99.25 | n<2 | 99.68 | +0.43 | |
| ERP-2508-S6110 | Semaglutide | 05 Aug 2025 | 2025-Q3 | 14 | 99.20 | 1.65 | 99.58 | +0.38 | |
| ERP-2508-M7270 | MOTS-c | 01 Aug 2025 | 2025-Q3 | 3 | 98.77 | 0.79 | 98.93 | +0.16 | |
| ERP-2507-A6393 | CJC-1295 with DAC | 23 Jul 2025 | 2025-Q4 | 6 | 99.72 | 0.90 | 99.90 | +0.18 | |
| ERP-2507-P8449 | Retatrutide | 02 Jul 2025 | 2025-Q3 | 2 | 98.24 | 0.59 | 98.61 | +0.37 | |
| ERP-2506-E6995 | CJC-1295 with DAC | 29 Jun 2025 | 2025-Q3 | 1 | 98.61 | n<2 | 99.83 | +1.22 | |
| ERP-2506-C7220 | Retatrutide | 16 Jun 2025 | 2025-Q3 | 3 | 98.54 | 0.29 | 99.00 | +0.46 | |
| ERP-2506-B7535 | CJC-1295 (no DAC) | 15 Jun 2025 | 2025-Q4 | 8 | 98.90 | 1.54 | 99.04 | +0.14 | |
| ERP-2505-U6755 | Ipamorelin | 16 May 2025 | 2025-Q4 | 4 | 99.84 | 1.41 | 99.90 | +0.06 | |
| ERP-2505-V8029 | Tirzepatide | 14 May 2025 | 2025-Q4 | 3 | 97.22 | 1.39 | 97.88 | +0.66 | |
| ERP-2504-G6947 | Kisspeptin-10 | 29 Apr 2025 | 2025-Q2 | 1 | 99.31 | n<2 | 99.90 | +0.59 | |
| ERP-2503-A7432 | Oxytocin | 15 Mar 2025 | 2025-Q2 | 5 | 98.82 | 0.74 | 99.50 | +0.68 | |
| ERP-2502-T7984 | Tirzepatide | 27 Feb 2025 | 2025-Q1 | 6 | 98.76 | 1.58 | 98.83 | +0.07 | |
| ERP-2502-S7254 | Ipamorelin | 16 Feb 2025 | 2025-Q3 | 2 | 99.11 | 0.20 | 99.74 | +0.63 | |
| ERP-2502-P7707 | BPC-157 | 11 Feb 2025 | 2025-Q1 | 10 | 99.81 | 0.61 | 99.90 | +0.09 | |
| ERP-2502-K7355 | Semaglutide | 11 Feb 2025 | 2025-Q3 | 2 | 98.92 | 1.04 | 99.64 | +0.72 | |
| ERP-2501-B6320 | MGF | 07 Jan 2025 | 2025-Q1 | 1 | 98.37 | n<2 | 99.49 | +1.12 | |
| ERP-2411-Y6431 | Follistatin-344 | 10 Nov 2024 | 2025-Q1 | 5 | — | n<2 | 99.00 | — | |
| ERP-2410-T8236 | BPC-157 | 19 Oct 2024 | 2025-Q1 | 5 | 98.92 | 0.47 | 99.29 | +0.37 | |
| ERP-2410-U7839 | TB-500 | 18 Oct 2024 | 2024-Q4 | 1 | 99.84 | n<2 | 99.27 | -0.57 | |
| ERP-2408-R7195 | GHRP-6 | 26 Aug 2024 | 2024-Q3 | 3 | 98.97 | 0.63 | 99.33 | +0.36 | SHARED BULK |
| ERP-2408-G6565 | Pemvidutide | 23 Aug 2024 | 2025-Q1 | 5 | 98.78 | 1.51 | 98.99 | +0.21 | |
| ERP-2408-G7213 | Ipamorelin | 11 Aug 2024 | 2024-Q3 | 6 | 99.93 | 0.41 | 99.90 | -0.03 | |
| ERP-2406-F7112 | Ipamorelin | 30 Jun 2024 | 2024-Q3 | 3 | 99.20 | 1.14 | 99.64 | +0.44 | |
| ERP-2406-E6999 | Tirzepatide | 25 Jun 2024 | 2024-Q3 | 4 | 98.05 | 1.45 | 98.24 | +0.19 | |
| ERP-2406-C7750 | Gonadorelin | 19 Jun 2024 | 2024-Q3 | 4 | 99.57 | 0.65 | 100.00 | +0.43 | |
| ERP-2405-P6825 | NAD+ | 20 May 2024 | 2024-Q4 | 2 | 98.37 | 0.29 | 98.74 | +0.37 | |
| ERP-2404-Y7646 | Semaglutide | 15 Apr 2024 | 2024-Q3 | 15 | 98.79 | 1.63 | 99.04 | +0.25 | |
| ERP-2402-J7609 | Kisspeptin-10 | 27 Feb 2024 | 2024-Q2 | 4 | 98.88 | 0.89 | 99.02 | +0.14 | |
| ERP-2402-U6523 | BPC-157 | 26 Feb 2024 | 2024-Q3 | 7 | 98.76 | 1.01 | 99.52 | +0.76 | |
| ERP-2402-D7200 | BPC-157 | 01 Feb 2024 | 2024-Q2 | 9 | 99.13 | 0.96 | 99.72 | +0.59 | |
| ERP-2401-K6373 | TB-500 | 26 Jan 2024 | 2024-Q2 | 5 | 99.39 | 0.60 | 99.49 | +0.10 | |
| ERP-2401-D6074 | Tirzepatide | 19 Jan 2024 | 2024-Q2 | 4 | 98.83 | 0.82 | 99.05 | +0.22 |